Founded in 2002, CovX Research LLC is a biotherapeutics company specializing in preclinical oncology/metabolic research and manufactures pharmaceuticals and medicines. The company uses its proprietary technology to discover and develop long-acting biological therapies. It combines therapeutic potential of peptides with the favorable properties of antibodies, which creates a new biopharmaceutical called a CovX-Body that possesses the pharmacologic properties of the peptide and the pharmacokinetic properties of monoclonal antibodies. Pfizer Inc. acquired CovX Research LLC. It is located in San Diego, Calif.
Partial Data by Infogroup (c) 2024. All rights reserved.